Ninety-day complication rate based on 532 Latarjet procedures in Dutch hospitals with different operation volumes
Hassanin Alkaduhimi(GGD Amsterdam), Denise Eygendaal(Erasmus University Rotterdam), Cornelis P.J. Visser(Alrijne Ziekenhuis), Nienke W. Willigenburg(OLVG), Heleen Sonneveld(Meander Medisch Centrum), Nienke Wolterbeek(St. Antonius Ziekenhuis), Tim Kraal(Flevoziekenhuis), Michał S. Gałek-Aldridge, Arthur van Noort(Erasmus MC), Petra E. Flikweert(Haga Hospital), W. Jaap Willems, Maartje E. Meier(Leiden University Medical Center), Arien J. Dijkstra(Flevoziekenhuis), Egbert J.D. Veen(University Medical Center Groningen), Ronald N. Wessel(St. Antonius Ziekenhuis), Tjarco D.W. Alta(Spaarne Ziekenhuis), Sebastiaan Floor(Central Military Hospital), Maaike P.J. van den Borne(Amphia Ziekenhuis), Jantsje H. Pasma(Haga Hospital), Eelco M. Nelissen, Michel P.J. van den Bekerom(Joint Research Centre), Rinco C. T. Koorevaar(Deventer Ziekenhuis)
Cited by 10
Related Papers
Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study
|The Lancet Respiratory Medicine|2020|306
Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study
|Journal of Bone and Mineral Research|2020|49
Incidence and Prevalence of Fibrous Dysplasia/McCune-Albright Syndrome: A Nationwide Registry-Based Study in Denmark
|The Journal of Clinical Endocrinology & Metabolism|2024|29
Regression of fibrous dysplasia in response to denosumab therapy: A report of two cases
|Bone Reports|2021|28
Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[18F]F PET-CT in Patients With Fibrous Dysplasia/McCune–Albright Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2021|27